Jonathan M. Schott
Physiology · 2002–2019
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Physiology — 55 citations into it; #1,489 of 2,276 by trust here, #965 by citations
- Psychiatry and Mental health — 37 citations into it
- Cognitive Neuroscience — 9 citations into it; #8,582 of 10,852 by trust here, #4,528 by citations
Whom Jonathan M. Schott trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jonathan M. Schott overall
Papers from Jonathan M. Schott's perspective
Ordered by how strongly the researchers Jonathan M. Schott trusts endorse each paper. Same corpus, a different order for every researcher.
- Classification of primary progressive aphasia and its variants (Neurology)
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
- Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (Lancet Neurology)
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline (Nature)
- The A4 Study: Stopping AD before Symptoms Begin? (Science Translational Medicine)
- The Neuropathology of Probable Alzheimer's Disease and Mild Cognitive Impairment (Annals of Neurology)
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease (Alzheimer's & Dementia)
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for… (Alzheimer's & Dementia)
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease (Nature)
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (New England Journal of Medicine)
Their papers
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept (2018) — 14 citations
- Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. (2004) — 1,042 citations
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. (2019) — 678 citations
- Short Acquisition Time PET/MR Pharmacokinetic Modelling Using CNNs (2018) — 5 citations
- Alzheimer's disease (2018) — 1,865 citations
- Attenuation Correction Synthesis for Hybrid PET-MR Scanners: Application to Brain Studies (2014) — 390 citations
- Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis (2011) — 891 citations
- Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI (2002) — 757 citations